Search results

219 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
UNC researchers awarded pilot grants for Zika research
UNC investigators will study diagnostics, transmission, and neurological effects of Zika, which has been reported in 62 countries and territories.
Located in News / 2016 / June
Diabetes drug lowers risk of cardiovascular complications, kidney disease
For the first time, a large clinical trial showed across-the-board cardiovascular benefit of a diabetes drug – liraglutide – a much-needed outcome for people with type 2 diabetes.
Located in News / 2016 / June
UNC clinical trials play crucial role in FDA approval for diabetes drug
Led by John Buse, MD, PhD, director of the UNC Diabetes Care Center, the clinical research of UNC doctors and the participation of thousands of patients culminates in a new, effective, and safe daily injectable drug to combat type-2 diabetes.
Located in News / 2016 / November
Scientists identify gene vital for rebuilding intestine after cancer treatment
Protecting the gastrointestinal system during chemotherapy or radiation could allow patients to tolerate more aggressive treatments to attack tumors.
Located in News / 2015 / August
UNC study: Mast cell tryptase test may aid in diagnosis of eosinophilic esophagitis
A pathology test may help doctors distinguish between two separate but overlapping esophageal disorders that require different courses of treatment, according to a study by researchers at the University of North Carolina at Chapel Hill.
Located in News / 2010 / May
Rheumatology/Allergy Specialty Clinic has relocated
The faculty and staff of the Rheumatology, Allergy, and Immunology Division at UNC are delighted to have moved to their new clinic, conveniently located at Carolina Pointe II, at the corner of Interstate 40 and Hwy. 54.
Located in Vital Signs / 2009 / Vital Signs - July 2, 2009
24-week hepatitis C treatment as effective as 48-week treatment
A new study, conducted in part at UNC, finds that a 24-week triple medication treatment course for hepatitis C is just as effective as a 48-week regimen.
Located in News / 2011 / September
Moll honored by National Alliance for Thrombosis and Thrombophilia
Stephan Moll, M.D., associate professor of hematology/oncology, received the first Medical and Scientific Leadership Award given by the National Alliance for Thrombosis and Thrombophilia (NATT).
Located in Vital Signs / 2008 / December
Chelminski, Meltzer-Brody named first Sanders Clinician Scholars
As the first two Sanders Clinician Scholars, Paul Chelminski, MD, MPH, and Samantha Meltzer-Brody, MD, MPH, will develop educational efforts to enhance supportive direct personal contact in the daily care of patients, and to teach others to do the same.
Located in News / 2012 / May
Spring allergy survival guide: When do you need to see the doctor?
UNC's Dr. Maya Jerath offers tips for surviving the spring allergy season.
Located in Vital Signs / 2009 / April